Skip to main content
  1. BAUS Home
  2. Professionals
  3. BAUS Business
  4. News

News

BAUS welcomes Prostate Cancer Research screening report

Chair of BAUS Section of Oncology, Vish Hanchanale and BAUS President Prof. Ian Pearce BAUS welcomes the recently published report from Prostate Cancer Research, released as part of their ‘It’s High Time to Screen’ campaign, which... Read more

BAUS Endorses the Leng Review to Enhance Governance and Patient Safety

BAUS Endorses the Leng Review to Enhance Governance and Patient Safety

Following an independent review into Physician Associate (PA) and Anaesthesia Associate (AA) professionals by Professor Gillian Leng CBE – initially commissioned in November 2024 – the Leng Review was successfully published in July 2025. BAUS... Read more

NICE Approves Use of New Treatment for Advanced Metastatic Bladder Cancer

NICE Approves Use of New Treatment for Advanced Metastatic Bladder Cancer

Enfortumab Vedotin combined with Pembrolizumab will now be available for eligible patients in the UK

The British Association of Urological Surgeons (BAUS) welcomes the decision by the National Institute for Health and Care Excellence (NICE) to approve the use of combination therapy enfortumab vedotin (Padcev) with pembrolizumab as a first-line... Read more

More Articles

BAUS Launches "Check In, Don't Check Out"...

Rectal Exam a “Poor Test for Prostate...

Voting Results - Deputy Vice Presidents...

Response statement in relation to prostate...

Appointment of New Audit Steering Group...

Consultant Job Planning 2024

Audit Steering Group Newsletter

Working Party on Sexual Misconduct in...

Looking for other articles? Check the archive →